Objectıves: Type 2 diabetes mellitus (T2DM) is known as a major risk factor for developing contrast-induced acute kidney injury (CI-AKI). However, it is not clear whether relatively chronic elevation of blood glucose level, or elevated glycosylated hemoglobin A1c (HbA1c) is associated with the incidence of CI-AKI. Methods: The present study prospectively enrolled 133 patientswith T2DM undergoing elective coronary angiography and/or intervention with a non-ionic low-osmolality contrast media (CM). The patients were divided into two groups: those with an HbA1c of <6.5% and those with an HbA1c of !6.5%. All patients had similar baseline characteristics and were hydrated appropriately. Iftaking metformin, it was continued because of the low risk of developing lactic acidosis in patients with an estimated glomerular filtration rate of !60 mL/ min/1.73 m2, as in this cohort. When necessary, insulin was administered to optimize glucose level in the peri-procedural period. The outcome was assessed by the occurrence of CI-AKI. Results: CI-AKI which was defined as !25% relative increase in serum creatinine from the baseline at 48 hours after administration of CM, occurred in 1/24 patients (4.1%) with optimal HbA1c levels (<6.5%), and 6/109 (5.5%) patients with high HbA1c levels (!6.5%), (p¼0.79). When the cut-offpoint of HbA1c was chosen as 7%, again there was no statistically significant difference between the two groups [2/ 41 (4.9%) vs. 5/92 (5.4%), p¼0.89]. When different CI-AKI definitions were taken into account, there was also no statistically significant difference between the two groups despite a high variability in the incidence of CI-AKI. Conclusıon: Elevated HbA1c is not associated with the incidence of CI-AKI in patients with T2DM undergoing coronary angiography and/or intervention. Aım: In this study, we aimed to investigate the effect of on admission bundle branch block (BBB) (right or left, new or previous) over in hospital and long term death, heart failure and rehospitalization, in patients treated with primary percutaneous coronary intervention (p-PCI). Study Design: A total of 2993 pateint (mean age 58.3, 675 females) who admitted to our center within 12 hours of chest pain and treated with p-PCI, between January 2006-February 2010 were retrospectively evaluated. Long term follow-up of the patients were prospectively done periodically (54 months median follow-up duration). On admission BBB (left, right or total) was present in 134 patients. Standart acute myocardial infarction ECG criteria in the presence of BBB were applied. The patients were grouped according to the presence (n¼134) or absence of BBB (n¼2859). Results: On admission, BBB was present in 134 (4.5%) of the patients. Of those, 50% (n¼67) were left BBB. The patients in the BBB group were older, more commonly had diabetes, hypertension, renal failure and presentation with cardiogenic shock and anterior myocardial infarction was more common. Final TIMI 3 flow (73.1% vs 91%, p<0.001) and post procedural left ventricular ejection fraction (38.2 AE 7.9 vs 47.2 AE 7.7%, p<0.001) were significantly lower and proximal left anterior descending location of infarct related artery and multivessel disease ratio were significantly higher in the BBB group. In hospital mortality (20.1% vs 3.0%) and clinical heart failure (59% vs 9%) were also significantly higher in the BBB group (p<0.001, fol all paramters). During long term follow-up, all cause mortality (41.8% vs 13.2%, p<0.001) and rehospitalization due to heart failure (33.3% vs 5.9%, p<0.001) were significantly higher in the BBB group and the presence of on admission BBB was an independent predictor of long term all cause mortality in the Cox-proportional hazard model (Hazard Ratio 2.97, 95% CI 1.23 -4.19, p<0.001). Conclusıon: The presence of on admission BBB is related to very high in hospital and long term mortality and heart failure symptoms in patients treated with p-PCI. The presence of BBB is an independent predictor of increased long term all cause mortality.
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The Background: A significant proportion of end stage renal disease patients undergoing percutaneous transluminal angioplasty (PTA) for arteriovenous fistula (AVF) have concomitant peripheral arterial disease (PAD), which plays a crucial role in the selection process of determining an optimal vascular access site. The aim of the present work was to determine the impact of PAD on 1-year AVF patency after percutaneous transluminal angioplasty in a large hemodialysis facility. Materıal and Methods: A retrospective analysis was performed for a total of 200 patients (92 females and 108 males, mean age:59AE13 years, mean hemodialysis vintage: 56AE36 months). Study patients were divided into 2 groups: Group 1 (patients without PAD; n¼147) and Group 2 (patients with a previous angiographic diagnosis of PAD; n¼53). The clinical and laboratory files were reviewed for the development of AVF dysfunction that required percutaneous intervention. Results: Compared to Group 1 patients, patients in Group 2 were elder (63AE10 vs 55AE13 years, p¼0,02) and had more diabetes (70% vs 25%, p¼0.016) and more history of documented coronary artery disease (42% vs 17%, p¼0.001), reflecting more frequent and severe comorbidities.
The review of clinical files revealed that 57 patients in Group 1 (38,8%) and 37 patients in Group 2 (69,8%) developed angiographically confirmed AVF dysfunction that required PTA in one year time (p<0,0001; Figure 1 ). In the multivariate regression analysis, PAD (HR 2.14, 95% CI 1.26-4.04, p¼0.006) was an independent predictor of 1-year AVF thrombosis after PTA. Dıscussıon: Assessment of PAD should play an important role in developing strategy for vascular access placement. 
